AHEAD OF PRINT
Three-year TAVI outcomes for BAV vs TAV
FREE ARTICLE - Dao Zhou et al.
January 20, 2022
Showing 1-16 of 16 articles
Coronary interventions
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial December 7, 2018 | 10.4244/EIJ-D-18-00762
Coronary interventions
Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study April 8, 2016 | 10.4244/EIJV11I14A315
Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?
March 20, 2015 | 10.4244/EIJV10I11A224
Minimising radial injury: prevention is better than cure
November 20, 2014 | 10.4244/EIJV10I7A142
Thrombus capture by withdrawal of an open filter device: a useful treatment for large non-occlusive coronary thrombus
October 20, 2014 | 10.4244/EIJV10I6A120
Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?
August 19, 2014 | 10.4244/EIJV10I4A73
Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms
June 27, 2012 | 10.4244/EIJV8I2A41
Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience
May 15, 2012 | 10.4244/EIJV8I1A13
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
May 15, 2012 | 10.4244/EIJV8I1A17
Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience
February 21, 2012 | 10.4244/EIJV7I10A188
Use of the Heartrail II catheter as a distal stent delivery device; an extended case series
June 30, 2009 | 10.4244/EIJV5I2A41